Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-22
2007-05-22
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000, C544S127000, C544S333000, C514S234200, C514S256000
Reexamination Certificate
active
11459489
ABSTRACT:
Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
REFERENCES:
patent: 3314941 (1967-04-01), Littell et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 4988815 (1991-01-01), Andre et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5175296 (1992-12-01), Gerster
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster
patent: 5268376 (1993-12-01), Gerster
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5367076 (1994-11-01), Gerster
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5693811 (1997-12-01), Lindstrom
patent: 5741908 (1998-04-01), Gerster et al.
patent: 5756747 (1998-05-01), Gerster et al.
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6069149 (2000-05-01), Nanba et al.
patent: 6083505 (2000-07-01), Miller et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6518265 (2003-02-01), Kato et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6696465 (2004-02-01), Dellaria et al.
patent: 6706728 (2004-03-01), Hedenstrom et al.
patent: 6743920 (2004-06-01), Lindstrom et al.
patent: 6756382 (2004-06-01), Rice et al.
patent: 6797718 (2004-09-01), Dellaria et al.
patent: 6818650 (2004-11-01), Griesgraber
patent: 6841678 (2005-01-01), Merli et al.
patent: 6852861 (2005-02-01), Merli et al.
patent: 2002/0016332 (2002-02-01), Slade
patent: 2002/0055517 (2002-05-01), Smith
patent: 2002/0058674 (2002-05-01), Hedenstrom et al.
patent: 2002/0107262 (2002-08-01), Lindstrom
patent: 2002/0110840 (2002-08-01), Tomai et al.
patent: 2003/0096835 (2003-05-01), Crooks et al.
patent: 2003/0130299 (2003-07-01), Crooks et al.
patent: 2003/0133913 (2003-07-01), Tomai et al.
patent: 2003/0139364 (2003-07-01), Krieg et al.
patent: 2003/0144286 (2003-07-01), Frenkel et al.
patent: 2003/0161797 (2003-08-01), Miller et al.
patent: 2003/0199538 (2003-10-01), Skwierczynski et al.
patent: 2004/0014779 (2004-01-01), Gorden et al.
patent: 2004/0091491 (2004-05-01), Kedi et al.
patent: 2004/0132079 (2004-07-01), Gupta et al.
patent: 2004/0141950 (2004-07-01), Noelle et al.
patent: 2004/0147543 (2004-07-01), Hays et al.
patent: 2004/0162309 (2004-08-01), Gorden et al.
patent: 2004/0171086 (2004-09-01), Fink et al.
patent: 2004/0175336 (2004-09-01), Egging et al.
patent: 2004/0176367 (2004-09-01), Griesgraber et al.
patent: 2004/0180919 (2004-09-01), Lee et al.
patent: 2004/0181130 (2004-09-01), Fox et al.
patent: 2004/0181211 (2004-09-01), Elliott et al.
patent: 2004/0191833 (2004-09-01), Fink et al.
patent: 2004/0192585 (2004-09-01), Fox et al.
patent: 2004/0197865 (2004-10-01), Gupta et al.
patent: 2004/0202720 (2004-10-01), Wightman et al.
patent: 2004/0214851 (2004-10-01), Birmachu et al.
patent: 2005/0054590 (2005-03-01), Averett
patent: 2005/0085500 (2005-04-01), Gutman et al.
patent: 2005/0165236 (2005-07-01), Colombo et al.
patent: 2005/0245562 (2005-11-01), Garcia-Echeverria et al.
patent: 0 394 026 (1990-10-01), None
patent: 1 104 764 (2001-06-01), None
patent: 9-208584 (1997-08-01), None
patent: 11-080156 (1999-03-01), None
patent: 11-222432 (1999-08-01), None
patent: 2000-247884 (2000-09-01), None
patent: WO 02/36592 (2002-05-01), None
patent: WO 05/018551 (2005-03-01), None
patent: WO 05/018555 (2005-03-01), None
patent: WO 05/018556 (2005-03-01), None
patent: WO 05/020999 (2005-03-01), None
patent: WO 05/032484 (2005-04-01), None
patent: WO 05/048933 (2005-06-01), None
patent: WO 05/048945 (2005-06-01), None
patent: WO 05/051317 (2005-06-01), None
patent: WO 05/051324 (2005-06-01), None
patent: WO 05/054237 (2005-06-01), None
patent: WO 05/054238 (2005-06-01), None
patent: WO 05/066169 (2005-07-01), None
patent: WO 05/066170 (2005-07-01), None
patent: WO 05/066172 (2005-07-01), None
patent: WO 05/076783 (2005-08-01), None
patent: WO 05/079195 (2005-09-01), None
patent: WO 05/094531 (2005-10-01), None
patent: WO 05/123079 (2005-12-01), None
patent: WO 05/123080 (2005-12-01), None
patent: WO 06/009826 (2006-01-01), None
patent: WO 06/009832 (2006-01-01), None
patent: WO 06/026760 (2006-03-01), None
patent: WO 06/028451 (2006-03-01), None
patent: WO 06/028545 (2006-03-01), None
patent: WO 06/028962 (2006-03-01), None
patent: WO 06/029115 (2006-03-01), None
patent: WO 06/031878 (2006-03-01), None
patent: WO 06/038923 (2006-04-01), None
patent: WO 06/004737 (2006-06-01), None
patent: WO 06/065280 (2006-06-01), None
patent: WO 06/074003 (2006-07-01), None
patent: WO 06/083400 (2006-08-01), None
patent: WO 06/083440 (2006-08-01), None
patent: WO 06/086449 (2006-08-01), None
patent: WO 06/086633 (2006-08-01), None
patent: WO 06/091394 (2006-08-01), None
patent: WO 06/091567 (2006-08-01), None
patent: WO 06/091568 (2006-08-01), None
patent: WO 06/091647 (2006-08-01), None
patent: WO 06/098852 (2006-09-01), None
Wozniak et al., “The Amination of 3-nitro-1, 5-naphthyridines by Liquid Ammonia/Potassium Permanganate1,2, A New and Convenient Amination Method.”,Journal of the Royal Netherlands Chemical Society, 102, pp. 511-513, Dec. 12, 1983.
Brennan et al., “Automated Bioassay of Interferons in Micro-test Plates.”,Biotechniques, Jun./Jul., 78, 1983.
Testerman et al., “Cytokine Induction by the Immunomodulators Imiqulmod and S-27609.”,Journal of Leukocyte Biology, vol. 58, pp. 365-372, Sep. 1995.
Bachman et al., “Synthesis of Substituted Quinolylamines. Derivatives of 4-Amino-7-Chloroquinoline.”,J. Org. Chem, 15, pp. 1278-1284 (1950).
Jaln et al., “Chemical and Pharmacological Investigations of Some ω-Substituted Alkylamino-3-aminopyridines.”,J. Med. Chem., 11, pp. 87-92 (1968).
Baranov et al., “Pyrazoles, Imidazoles, and Other 5-Membered Rings.”,Chem. Abs.85, 94362, (1978).
Berényi et al., “Ring Transformation of Condensed Dihydro-as-triazines.”,J. Heterocyclic Chem., 18, pp. 1537-1540 (1981).
Chollet et al., “Development of a Topically Active Imiquimod Formulation.”,Pharmaceutical Development and Technology, 4(1), pp. 35-43 (1999).
Izumi et al., “1H-Imidazo[4,5-c]quinoline Derivatives as Novel Potent TNF-α Suppressors: Synthesis and Structure-Activity Relationship of 1-, 2- and 4-Substituted-1H-imidazo[4,5-c]pyridines.”,Bioorganic&Medicinal Chemistry, 11, pp. 2541-2550 (2003).
Dellaria Joseph F.
Dressel Luke T.
Heppner Philip D.
Jacobsen John R.
Lindstrom Kyle J.
3M Innovative Properties Company
Aulakh Charanjit S.
Ersfeld Dean A.
LandOfFree
Ether substituted imidazopyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ether substituted imidazopyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ether substituted imidazopyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3824140